SL-01, an oral derivative of gemcitabine, inhibited human breast cancer growth through induction of apoptosis.

Li, Yuan-Yuan; Qin, Yi-Zhuo; Wang, Rui-Qi; Li, Wen-Bao; Qu, Xian-Jun

Li, Yuan-Yuan; Qin, Yi-Zhuo; Wang, Rui-Qi; Li, Wen-Bao; Qu, Xian-Jun.

Affiliation

Li YY; Department of Pharmacology, School of Pharmaceutical Sciences, Shandong University, Jinan 250012, China.

Biochem Biophys Res Commun ; 438(2): 402-9, 2013 Aug 23.

Article in En | MEDLINE | ID: mdl-23899521

Subject(s)

Antineoplastic Agents/pharmacology; Apoptosis; Breast Neoplasms/pathology; Deoxycytidine/analogs & derivatives; Administration, Oral; Animals; Cell Cycle/drug effects; Cell Line, Tumor; Deoxycytidine/pharmacology; Dose-Response Relationship, Drug; Drug Design; Female; Humans; Mice; Mice, Inbred BALB C; Xenograft Model Antitumor Assays; Gemcitabine

Key words

Apoptosis; Gemcitabine; Human breast cancer; Inhibitory effect; Oral derivative; Toxicity

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Apoptosis / Deoxycytidine / Antineoplastic Agents Limits: Animals / Female / Humans Language: En Journal: Biochem Biophys Res Commun Year: 2013 Document type: Article Affiliation country: China Country of publication: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google